Medical Care

Global Targeted Protein Degradation Market Research Report 2025

The global market for Targeted Protein Degradation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Targeted Protein Degradation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Targeted Protein Degradation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Targeted Protein Degradation in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Targeted Protein Degradation include 5AM Venture Management LLC, AbbVie Inc, Almac Group, Amgen Inc., Bayer AG, Biogen Inc., C4 Therapeutics, Cosmo Bio USA, Covance Inc, Eli Lilly and Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Protein Degradation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Protein Degradation.
The Targeted Protein Degradation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Protein Degradation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Protein Degradation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
5AM Venture Management LLC
AbbVie Inc
Almac Group
Amgen Inc.
Bayer AG
Biogen Inc.
C4 Therapeutics
Cosmo Bio USA
Covance Inc
Eli Lilly and Company
Gilead Sciences, Inc
GlaxoSmithKline plc
Merck KGaA
Mission Therapeutics
Novartis AG
Pfizer Inc
Promega
Segment by Type
Oral
Intravenous
Others
Segment by Application
Hospital
Research Institute
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Protein Degradation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Others
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Protein Degradation Market Perspective (2020-2031)
2.2 Global Targeted Protein Degradation Growth Trends by Region
2.2.1 Global Targeted Protein Degradation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Protein Degradation Historic Market Size by Region (2020-2025)
2.2.3 Targeted Protein Degradation Forecasted Market Size by Region (2026-2031)
2.3 Targeted Protein Degradation Market Dynamics
2.3.1 Targeted Protein Degradation Industry Trends
2.3.2 Targeted Protein Degradation Market Drivers
2.3.3 Targeted Protein Degradation Market Challenges
2.3.4 Targeted Protein Degradation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Players by Revenue (2020-2025)
3.1.2 Global Targeted Protein Degradation Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Protein Degradation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Protein Degradation Revenue
3.4 Global Targeted Protein Degradation Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Revenue in 2024
3.5 Global Key Players of Targeted Protein Degradation Head office and Area Served
3.6 Global Key Players of Targeted Protein Degradation, Product and Application
3.7 Global Key Players of Targeted Protein Degradation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Protein Degradation Breakdown Data by Type
4.1 Global Targeted Protein Degradation Historic Market Size by Type (2020-2025)
4.2 Global Targeted Protein Degradation Forecasted Market Size by Type (2026-2031)
5 Targeted Protein Degradation Breakdown Data by Application
5.1 Global Targeted Protein Degradation Historic Market Size by Application (2020-2025)
5.2 Global Targeted Protein Degradation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Protein Degradation Market Size (2020-2031)
6.2 North America Targeted Protein Degradation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Protein Degradation Market Size by Country (2020-2025)
6.4 North America Targeted Protein Degradation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Market Size (2020-2031)
7.2 Europe Targeted Protein Degradation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Protein Degradation Market Size by Country (2020-2025)
7.4 Europe Targeted Protein Degradation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Market Size (2020-2031)
8.2 Asia-Pacific Targeted Protein Degradation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Protein Degradation Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Protein Degradation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Protein Degradation Market Size (2020-2031)
9.2 Latin America Targeted Protein Degradation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Protein Degradation Market Size by Country (2020-2025)
9.4 Latin America Targeted Protein Degradation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Market Size (2020-2031)
10.2 Middle East & Africa Targeted Protein Degradation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Protein Degradation Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Protein Degradation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 5AM Venture Management LLC
11.1.1 5AM Venture Management LLC Company Details
11.1.2 5AM Venture Management LLC Business Overview
11.1.3 5AM Venture Management LLC Targeted Protein Degradation Introduction
11.1.4 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2020-2025)
11.1.5 5AM Venture Management LLC Recent Development
11.2 AbbVie Inc
11.2.1 AbbVie Inc Company Details
11.2.2 AbbVie Inc Business Overview
11.2.3 AbbVie Inc Targeted Protein Degradation Introduction
11.2.4 AbbVie Inc Revenue in Targeted Protein Degradation Business (2020-2025)
11.2.5 AbbVie Inc Recent Development
11.3 Almac Group
11.3.1 Almac Group Company Details
11.3.2 Almac Group Business Overview
11.3.3 Almac Group Targeted Protein Degradation Introduction
11.3.4 Almac Group Revenue in Targeted Protein Degradation Business (2020-2025)
11.3.5 Almac Group Recent Development
11.4 Amgen Inc.
11.4.1 Amgen Inc. Company Details
11.4.2 Amgen Inc. Business Overview
11.4.3 Amgen Inc. Targeted Protein Degradation Introduction
11.4.4 Amgen Inc. Revenue in Targeted Protein Degradation Business (2020-2025)
11.4.5 Amgen Inc. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Targeted Protein Degradation Introduction
11.5.4 Bayer AG Revenue in Targeted Protein Degradation Business (2020-2025)
11.5.5 Bayer AG Recent Development
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Details
11.6.2 Biogen Inc. Business Overview
11.6.3 Biogen Inc. Targeted Protein Degradation Introduction
11.6.4 Biogen Inc. Revenue in Targeted Protein Degradation Business (2020-2025)
11.6.5 Biogen Inc. Recent Development
11.7 C4 Therapeutics
11.7.1 C4 Therapeutics Company Details
11.7.2 C4 Therapeutics Business Overview
11.7.3 C4 Therapeutics Targeted Protein Degradation Introduction
11.7.4 C4 Therapeutics Revenue in Targeted Protein Degradation Business (2020-2025)
11.7.5 C4 Therapeutics Recent Development
11.8 Cosmo Bio USA
11.8.1 Cosmo Bio USA Company Details
11.8.2 Cosmo Bio USA Business Overview
11.8.3 Cosmo Bio USA Targeted Protein Degradation Introduction
11.8.4 Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2020-2025)
11.8.5 Cosmo Bio USA Recent Development
11.9 Covance Inc
11.9.1 Covance Inc Company Details
11.9.2 Covance Inc Business Overview
11.9.3 Covance Inc Targeted Protein Degradation Introduction
11.9.4 Covance Inc Revenue in Targeted Protein Degradation Business (2020-2025)
11.9.5 Covance Inc Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Targeted Protein Degradation Introduction
11.10.4 Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2020-2025)
11.10.5 Eli Lilly and Company Recent Development
11.11 Gilead Sciences, Inc
11.11.1 Gilead Sciences, Inc Company Details
11.11.2 Gilead Sciences, Inc Business Overview
11.11.3 Gilead Sciences, Inc Targeted Protein Degradation Introduction
11.11.4 Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2020-2025)
11.11.5 Gilead Sciences, Inc Recent Development
11.12 GlaxoSmithKline plc
11.12.1 GlaxoSmithKline plc Company Details
11.12.2 GlaxoSmithKline plc Business Overview
11.12.3 GlaxoSmithKline plc Targeted Protein Degradation Introduction
11.12.4 GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2020-2025)
11.12.5 GlaxoSmithKline plc Recent Development
11.13 Merck KGaA
11.13.1 Merck KGaA Company Details
11.13.2 Merck KGaA Business Overview
11.13.3 Merck KGaA Targeted Protein Degradation Introduction
11.13.4 Merck KGaA Revenue in Targeted Protein Degradation Business (2020-2025)
11.13.5 Merck KGaA Recent Development
11.14 Mission Therapeutics
11.14.1 Mission Therapeutics Company Details
11.14.2 Mission Therapeutics Business Overview
11.14.3 Mission Therapeutics Targeted Protein Degradation Introduction
11.14.4 Mission Therapeutics Revenue in Targeted Protein Degradation Business (2020-2025)
11.14.5 Mission Therapeutics Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Targeted Protein Degradation Introduction
11.15.4 Novartis AG Revenue in Targeted Protein Degradation Business (2020-2025)
11.15.5 Novartis AG Recent Development
11.16 Pfizer Inc
11.16.1 Pfizer Inc Company Details
11.16.2 Pfizer Inc Business Overview
11.16.3 Pfizer Inc Targeted Protein Degradation Introduction
11.16.4 Pfizer Inc Revenue in Targeted Protein Degradation Business (2020-2025)
11.16.5 Pfizer Inc Recent Development
11.17 Promega
11.17.1 Promega Company Details
11.17.2 Promega Business Overview
11.17.3 Promega Targeted Protein Degradation Introduction
11.17.4 Promega Revenue in Targeted Protein Degradation Business (2020-2025)
11.17.5 Promega Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Protein Degradation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Intravenous
Table 4. Key Players of Others
Table 5. Global Targeted Protein Degradation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Targeted Protein Degradation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Targeted Protein Degradation Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Targeted Protein Degradation Market Share by Region (2020-2025)
Table 9. Global Targeted Protein Degradation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Targeted Protein Degradation Market Share by Region (2026-2031)
Table 11. Targeted Protein Degradation Market Trends
Table 12. Targeted Protein Degradation Market Drivers
Table 13. Targeted Protein Degradation Market Challenges
Table 14. Targeted Protein Degradation Market Restraints
Table 15. Global Targeted Protein Degradation Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Targeted Protein Degradation Market Share by Players (2020-2025)
Table 17. Global Top Targeted Protein Degradation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation as of 2024)
Table 18. Ranking of Global Top Targeted Protein Degradation Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Targeted Protein Degradation Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Targeted Protein Degradation, Headquarters and Area Served
Table 21. Global Key Players of Targeted Protein Degradation, Product and Application
Table 22. Global Key Players of Targeted Protein Degradation, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Protein Degradation Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Targeted Protein Degradation Revenue Market Share by Type (2020-2025)
Table 26. Global Targeted Protein Degradation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Targeted Protein Degradation Revenue Market Share by Type (2026-2031)
Table 28. Global Targeted Protein Degradation Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Targeted Protein Degradation Revenue Market Share by Application (2020-2025)
Table 30. Global Targeted Protein Degradation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Targeted Protein Degradation Revenue Market Share by Application (2026-2031)
Table 32. North America Targeted Protein Degradation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Targeted Protein Degradation Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Targeted Protein Degradation Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Targeted Protein Degradation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Targeted Protein Degradation Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Targeted Protein Degradation Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Targeted Protein Degradation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Targeted Protein Degradation Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Targeted Protein Degradation Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Targeted Protein Degradation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Targeted Protein Degradation Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Targeted Protein Degradation Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Targeted Protein Degradation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Targeted Protein Degradation Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Targeted Protein Degradation Market Size by Country (2026-2031) & (US$ Million)
Table 47. 5AM Venture Management LLC Company Details
Table 48. 5AM Venture Management LLC Business Overview
Table 49. 5AM Venture Management LLC Targeted Protein Degradation Product
Table 50. 5AM Venture Management LLC Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 51. 5AM Venture Management LLC Recent Development
Table 52. AbbVie Inc Company Details
Table 53. AbbVie Inc Business Overview
Table 54. AbbVie Inc Targeted Protein Degradation Product
Table 55. AbbVie Inc Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 56. AbbVie Inc Recent Development
Table 57. Almac Group Company Details
Table 58. Almac Group Business Overview
Table 59. Almac Group Targeted Protein Degradation Product
Table 60. Almac Group Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 61. Almac Group Recent Development
Table 62. Amgen Inc. Company Details
Table 63. Amgen Inc. Business Overview
Table 64. Amgen Inc. Targeted Protein Degradation Product
Table 65. Amgen Inc. Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 66. Amgen Inc. Recent Development
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Targeted Protein Degradation Product
Table 70. Bayer AG Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. Biogen Inc. Company Details
Table 73. Biogen Inc. Business Overview
Table 74. Biogen Inc. Targeted Protein Degradation Product
Table 75. Biogen Inc. Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 76. Biogen Inc. Recent Development
Table 77. C4 Therapeutics Company Details
Table 78. C4 Therapeutics Business Overview
Table 79. C4 Therapeutics Targeted Protein Degradation Product
Table 80. C4 Therapeutics Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 81. C4 Therapeutics Recent Development
Table 82. Cosmo Bio USA Company Details
Table 83. Cosmo Bio USA Business Overview
Table 84. Cosmo Bio USA Targeted Protein Degradation Product
Table 85. Cosmo Bio USA Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 86. Cosmo Bio USA Recent Development
Table 87. Covance Inc Company Details
Table 88. Covance Inc Business Overview
Table 89. Covance Inc Targeted Protein Degradation Product
Table 90. Covance Inc Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 91. Covance Inc Recent Development
Table 92. Eli Lilly and Company Company Details
Table 93. Eli Lilly and Company Business Overview
Table 94. Eli Lilly and Company Targeted Protein Degradation Product
Table 95. Eli Lilly and Company Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 96. Eli Lilly and Company Recent Development
Table 97. Gilead Sciences, Inc Company Details
Table 98. Gilead Sciences, Inc Business Overview
Table 99. Gilead Sciences, Inc Targeted Protein Degradation Product
Table 100. Gilead Sciences, Inc Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 101. Gilead Sciences, Inc Recent Development
Table 102. GlaxoSmithKline plc Company Details
Table 103. GlaxoSmithKline plc Business Overview
Table 104. GlaxoSmithKline plc Targeted Protein Degradation Product
Table 105. GlaxoSmithKline plc Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 106. GlaxoSmithKline plc Recent Development
Table 107. Merck KGaA Company Details
Table 108. Merck KGaA Business Overview
Table 109. Merck KGaA Targeted Protein Degradation Product
Table 110. Merck KGaA Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 111. Merck KGaA Recent Development
Table 112. Mission Therapeutics Company Details
Table 113. Mission Therapeutics Business Overview
Table 114. Mission Therapeutics Targeted Protein Degradation Product
Table 115. Mission Therapeutics Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 116. Mission Therapeutics Recent Development
Table 117. Novartis AG Company Details
Table 118. Novartis AG Business Overview
Table 119. Novartis AG Targeted Protein Degradation Product
Table 120. Novartis AG Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 121. Novartis AG Recent Development
Table 122. Pfizer Inc Company Details
Table 123. Pfizer Inc Business Overview
Table 124. Pfizer Inc Targeted Protein Degradation Product
Table 125. Pfizer Inc Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 126. Pfizer Inc Recent Development
Table 127. Promega Company Details
Table 128. Promega Business Overview
Table 129. Promega Targeted Protein Degradation Product
Table 130. Promega Revenue in Targeted Protein Degradation Business (2020-2025) & (US$ Million)
Table 131. Promega Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report


List of Figures
Figure 1. Targeted Protein Degradation Picture
Figure 2. Global Targeted Protein Degradation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Protein Degradation Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Intravenous Features
Figure 6. Others Features
Figure 7. Global Targeted Protein Degradation Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Targeted Protein Degradation Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Targeted Protein Degradation Report Years Considered
Figure 12. Global Targeted Protein Degradation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Targeted Protein Degradation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Targeted Protein Degradation Market Share by Region: 2024 VS 2031
Figure 15. Global Targeted Protein Degradation Market Share by Players in 2024
Figure 16. Global Top Targeted Protein Degradation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Targeted Protein Degradation Revenue in 2024
Figure 18. North America Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Targeted Protein Degradation Market Share by Country (2020-2031)
Figure 20. United States Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Targeted Protein Degradation Market Share by Country (2020-2031)
Figure 24. Germany Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Targeted Protein Degradation Market Share by Region (2020-2031)
Figure 32. China Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Targeted Protein Degradation Market Share by Country (2020-2031)
Figure 40. Mexico Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Targeted Protein Degradation Market Share by Country (2020-2031)
Figure 44. Turkey Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Targeted Protein Degradation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. 5AM Venture Management LLC Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 48. AbbVie Inc Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 49. Almac Group Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 50. Amgen Inc. Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 51. Bayer AG Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 52. Biogen Inc. Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 53. C4 Therapeutics Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 54. Cosmo Bio USA Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 55. Covance Inc Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 57. Gilead Sciences, Inc Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 58. GlaxoSmithKline plc Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 59. Merck KGaA Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 60. Mission Therapeutics Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 61. Novartis AG Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 62. Pfizer Inc Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 63. Promega Revenue Growth Rate in Targeted Protein Degradation Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies